COVID-19 is an emerging, rapidly evolving siituation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Henry Rodriguez, Ph.D., M.S., M.B.A.

Office Director

Henry Rodriguez

On detail at the White House (WH46) -- Assistant Director for Strategic Health and Cancer Science, White House Office of Science and Technology Policy, Executive Office of the President. Responsible for leading strategies related to cancer and other diseases, and advancing innovations to improve health.

Dr. Henry Rodriguez is the Founding Director of the Office of Cancer Clinical Proteomics Research at the National Cancer Institute (NCI), National Institutes of Health (NIH). Dr. Rodriguez is also a member of NCI’s Senior Leadership. A cell and molecular biologist with a background in business, Dr. Rodriguez’s biomedical research has focused on mechanisms of cancer in basic and clinical science, and the development of measurement science, standards, and technology.

Previously, Dr. Rodriguez served as Acting Deputy Director of the Center for Strategic Scientific Initiatives at the NCI, and held multiple roles at the National Institute of Standards and Technology (Department of Commerce), including Director of a Cell and Tissue metrology research group of which he founded; Health Sciences Program/Policy Analyst in the Office of the Director that involved coordination with leadership in the Department of Commerce, Congress, and the Department of Health and Human Services Secretary’s Advisory Committee on Genetic, Health and Society; and Principal Investigator in a DNA Technologies Group.

Dr. Rodriguez is a member of several organizations and recipient of numerous honors. Dr. Rodriguez has authored more than 150 original research papers, including co-editing a best-selling book on oxidative stress and aging. Dr. Rodriguez earned his A.A. in biology from Miami Dade Community College, B.S. in biology/chemistry and M.S. in biology from Florida International University, Ph.D. in cell and molecular biology from Boston University, and M.B.A. in finance and management from Johns Hopkins University Carey Business School. Fellowships were conducted at the Scripps Research Institute and City of Hope Comprehensive Cancer Center.